טוען...
Disclosure of Industry Payments to Prescribers: Industry Payments Might be a Factor Impacting Generic Drug Prescribing
PURPOSE: Pharmaceutical companies paid at least $3.91 billion to prescribers in 2013, yet evidence indicating whether industry payments shift prescribing away from generics is limited. This study examined the association between amount of industry payments to prescribers and generic drug prescribing...
שמור ב:
| הוצא לאור ב: | Pharmacoepidemiol Drug Saf |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5856251/ https://ncbi.nlm.nih.gov/pubmed/28485111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4224 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|